Major osteoporotic fragility fractures: Risk factor updates and societal impact, World J Orthop, vol.7, issue.3, pp.171-81, 2016. ,
DOI : 10.5312/wjo.v7.i3.171
URL : https://doi.org/10.5312/wjo.v7.i3.171
Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study, Thyroid, vol.23, issue.9, pp.1066-73, 2013. ,
, J R Soc Med, vol.107, issue.9, pp.376-383, 2014.
Nonparathyroid Endocrine Bone Disease, Proc R Soc Med, vol.60, issue.11, pp.1131-1132, 1967. ,
Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies, Osteoporos Int, vol.27, issue.1, pp.115-140, 2016. ,
A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma, J Clin Endocrinol Metab, vol.72, issue.6, pp.1184-1192, 1991. ,
The effects of thyrotropin-suppressing therapy on bone metabolism in patients with welldifferentiated thyroid carcinoma, Bone, vol.71, pp.101-106, 2015. ,
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis, J Clin Endocrinol Metab, vol.81, issue.12, pp.4278-89, 1996. ,
Influence of thyroid hormone therapy on the fracture rate-A claims data cohort study, Bone, vol.86, pp.86-90, 2016. ,
Longterm thyroxine treatment and bone mineral density, Lancet, vol.340, issue.8810, pp.9-13, 1992. ,
Influence of hyper-and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk, Calcif Tissue Int, vol.77, issue.3, pp.139-183, 2005. ,
Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study, J Clin Endocrinol Metab, vol.97, issue.11, pp.3926-3960, 2012. ,
Comorbid cognitive impairment and depression is a significant predictor of poor outcomes in hip fracture rehabilitation, Int Psychogeriatr, vol.22, issue.2, pp.246-53, 2010. ,
Sensory impairment in hipfracture patients 65 years or older and effects of hearing/vision interventions on fall frequency, J Multidiscip Healthc, 2008. ,
, Dose/kg of Levothyroxine treatment (ref: 0.5 ug/kg et +)
, Dose/day of Levothyroxine treatment (ref: 50 ug/day et +)
,
,
, Biphosphonate treatment (ref: no)
, High dose of steroids treatment
, Steroids treatment (ref: no)
, Diabetes
,
,
, HRT therapy
,
, Psychotropic treatment (ref: one psychotropic treatment)
, OR : Odds Ratio; CI : Confidence Interval; HRT : hormone replacement therapy. * Stepwise variable selection with significance level for entry into the model at 0.2 and with significance level for staying in the model at 0.05 were used